Gujarat Themis Biosyn Ltd
GUJTHEM
Company Profile
Business description
Gujarat Themis Biosyn Ltd is engaged in manufacturing, exporting, and selling of bulk drugs on a job-work basis. The company operates in one segment which is pharmaceuticals. Its products include Rifamycin-S, which is an intermediate for Rifampicin for the treatment of tuberculosis (TB), and Lovastatin.
Contact
S.V Road
Themis House, 11/12 Udyog Nagar
Goregaon (West)
MumbaiMH400104
INDT: +91 2267607080
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
224
Stocks News & Analysis
stocks
Alphabet raises $80 billion for AI efforts
$10 billion private placement to Berkshire Hathaway as part of equity raise.
stocks
SpaceX: What investors need to know about its enormous upcoming IPO
Morningstar launches research coverage of SpaceX.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,017.20 | 3.10 | -0.03% |
| CAC 40 | 8,163.06 | 46.03 | -0.56% |
| DAX 40 | 24,793.55 | 330.62 | -1.32% |
| Dow JONES (US) | 50,934.45 | 373.34 | -0.73% |
| FTSE 100 | 10,337.74 | 35.77 | -0.34% |
| HKSE | 25,633.21 | 405.11 | -1.56% |
| NASDAQ | 26,937.12 | 156.79 | -0.58% |
| Nikkei 225 | 68,402.13 | 1,667.89 | 2.50% |
| NZX 50 Index | 13,115.08 | 55.63 | -0.42% |
| S&P 500 | 7,577.59 | 32.19 | -0.42% |
| S&P/ASX 200 | 8,785.70 | 5.90 | 0.07% |
| SSE Composite Index | 4,083.97 | 8.87 | 0.22% |